🤖Thrilled to welcome the H to the #ElaiaFamily by joining their $220m seed funding round! Foundational action models represent a major leap forward in AI, enabling machines to not just process data but to understand, predict, and take actions based on complex insights.

💥 We’re super excited to announce the first close of our newest deep tech seed fund: DTS3 at €60m! Read more about our new fund in @TechCrunch (thank you @abracarioca)👉

🇪🇺 It's no secret that we believe Europe is a hub for innovation. The #EuropeanDynamism50 Report unites leaders that embody a dynamic spirit: founders who see the value in bringing the best of 🇪🇺 tech, ideas, & progress together to address many of the world's critical challenges

With insights from @gleamer_ai and @huggingface, learn more about how we’ve (nearly) eaten the internet, the different formats of synthetic data, and why we’re keeping an eye on this emerging field here @Elaia_Partners.

🧐What does @whereswaldo have to do with synthetic data? Find out more in our latest Medium article! @ancirarturo dives into the rise of synthetic data in an AI-world and what it means for the future of computing. Read it all here ➡️

⭐️ Happy 2024! ⭐️ From our team to yours, we wish you a very Happy New Year filled with joy and good health. We're excited to see what 2024 has in store!

What a move ! 👍 Congrats aux teams d' @Elaia_Partners et à @XavLaz pour ce projet.

Le fonds @Elaia_Partners va s’associer à @Lazard pour décupler sa force de frappe en #Europe 🇪🇺🚀

🎄 🥳 Ending 2023 with such a great news ! It's out!! @Elaia_Partners is entering into exclusive negotiations to form a strategic partnership with @LazardAsset and develop a new European private technology platform, with the project of adding a Growth Tech Fund.

💥The news is out... We are entering into exclusive negotiations with @LazardGestion to form a strategic partnership to develop a leading and comprehensive European private technology investment platform. https://t.co/pAvbGOSOiU

As historic investors in @aqemia since 2019, we’re so proud of this team led by @maxlevesq and Emmanuelle Martiano Rolland. Please join us in congratulating the entire AQEMIA team for this milestone! 🎉 Read more in Bloomberg ⬇️ https://t.co/IvxCAqS96V

🔥 @aqemia , a drug discovery company powered by GenAI, has signed a €140 million multi-year partnership with global pharma company, @sanofi !

🎉 Big news for #MablinkBiosciences and @Elaia_Partners ! ⚡️ Our latest Medium post dives into the partnership we built with the team, especially #Mablink’s co-founder and CEO, Jean-Guillaume Lafay all the way from seed round to acquisition.

Exciting news from #AzaleaVision! 🚀 Azalea Vision just completed their first successful on-eye demonstration of Azalea’s revolutionary ophthalmological care technology 👁️.

In 🇫🇷

Read more here!

👾 @harfanglab is expanding across Europe with a new €25 million Series A round! As our 2nd investment with HarfangLab, we’re proud to continue backing their innovative technology and stellar team as they continue to build on their reputation for technical excellence.

🍴We’re hosting a private chef dinner with @inovia next Tuesday. We’re bringing together some of the best founders to celebrate our guest of honor @FrancoiseBr and we only have 2 seats left, who should we invite? Please DM.

🇬🇧 version can be found here:

The outburst of generative AI into our daily lives can’t help but question the supremacy of human intelligence over the machine 🎙️ @XavLaz shared with @bymaddyness our view on how can tech entrepreneurs & developers adapt to #GenAI with @Mirakl & Arsen https://t.co/fKoE7XHmnf